The therapeutic promise of Mesenchymal Stromal Cells (MSCs) is increasingly attributed to their paracrine activity rather than direct differentiation.
This article provides a comprehensive analysis of evidence-based strategies to improve stem cell retention in target tissues, a critical challenge limiting the therapeutic efficacy of regenerative medicine.
Mesenchymal stem cell (MSC) therapy holds immense promise for regenerative medicine, but its clinical translation is significantly hampered by the persistent challenge of poor cell engraftment and survival post-delivery.
This article provides a comprehensive guide for researchers and drug development professionals on the collection and concentration of mesenchymal stromal cell (MSC)-conditioned medium (CM).
Acute kidney injury (AKI) remains a significant clinical challenge with limited treatment options.
This article synthesizes current research on the cytoprotective paracrine effects of adrenomedullin (ADM) and insulin-like growth factor-1 (IGF-1), two potent pleiotropic factors.
This article comprehensively explores how three-dimensional (3D) culture systems profoundly enhance the paracrine function of Mesenchymal Stem/Stromal Cells (MSCs), a critical factor for their therapeutic efficacy in regenerative medicine.
This article provides a comprehensive analysis of mesenchymal stromal cell (MSC) preconditioning, a pivotal strategy to enhance the therapeutic potential of their paracrine activity.
This article synthesizes current research on the paracrine mechanisms by which transplanted stem cells activate endogenous cardiac stem and progenitor cells to promote heart repair.
This article synthesizes current research on how hypoxic stress modulates the production of paracrine factors from stem cells, with a focus on mesenchymal stem cells (MSCs).